• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Patient needs and preferences for herb-drug-disease interaction alerts: a structured interview study.患者对草药-药物-疾病相互作用警报的需求和偏好:一项结构化访谈研究。
BMC Complement Altern Med. 2017 May 19;17(1):272. doi: 10.1186/s12906-017-1630-6.
2
Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives.医生与癌症患者之间关于补充和替代医学的沟通:探索患者的观点。
Psychooncology. 2002 May-Jun;11(3):212-20. doi: 10.1002/pon.552.
3
Risk of interactions between complementary and alternative medicine and medication for comorbidities in patients with melanoma.黑色素瘤患者中补充和替代医学与合并症药物之间相互作用的风险。
Med Oncol. 2016 May;33(5):52. doi: 10.1007/s12032-016-0764-6. Epub 2016 Apr 18.
4
The use of complementary and alternative medicine by patients in routine care and the risk of interactions.患者在常规护理中使用补充和替代医学及其相互作用的风险。
J Cancer Res Clin Oncol. 2018 Mar;144(3):551-557. doi: 10.1007/s00432-018-2587-7. Epub 2018 Jan 22.
5
Interactions between traditional Chinese medicine and western drugs in Taiwan: A population-based study.台湾地区的中医药与西药相互作用:一项基于人群的研究。
Comput Methods Programs Biomed. 2015 Dec;122(3):462-70. doi: 10.1016/j.cmpb.2015.09.006. Epub 2015 Sep 10.
6
Complementary and alternative medicine use among cancer patients in Palestine with special reference to safety-related concerns.巴勒斯坦癌症患者对补充替代医学的使用情况,特别关注与安全相关的问题。
J Ethnopharmacol. 2016 Jul 1;187:104-22. doi: 10.1016/j.jep.2016.04.038. Epub 2016 Apr 25.
7
Inpatients' Preferences, Beliefs, and Stated Willingness to Pay for Complementary and Alternative Medicine Treatments.住院患者对补充和替代医学治疗的偏好、信念及支付意愿声明
J Altern Complement Med. 2017 Apr;23(4):259-263. doi: 10.1089/acm.2016.0288. Epub 2017 Jan 23.
8
Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.参加I期试验的晚期癌症患者的补充和替代医学:一项关于预后、生活质量及决策偏好的研究。
J Clin Oncol. 2007 Feb 10;25(5):548-54. doi: 10.1200/JCO.2005.03.9800.
9
Complementary and alternative medicines versus prescription drugs: perceptions of emergency department patients.补充和替代药物与处方药:急诊科患者的看法
Emerg Med J. 2006 Apr;23(4):266-8. doi: 10.1136/emj.2005.026138.
10
Who uses complementary and alternative therapies in regional South Australia? Evidence from the Whyalla Intergenerational Study of Health.南澳大利亚地区哪些人使用补充和替代疗法?来自怀阿拉代际健康研究的证据。
Aust Health Rev. 2013 Feb;37(1):104-11. doi: 10.1071/AH11130.

引用本文的文献

1
Perspectives, Experiences, and Practices of Healthcare Professionals and Patients Towards Herb-Drug Interaction: A Systematic Review of Qualitative Studies.医疗保健专业人员和患者对草药-药物相互作用的观点、经验和实践:定性研究的系统评价
Phytother Res. 2025 Jan;39(1):505-520. doi: 10.1002/ptr.8384. Epub 2024 Nov 13.
2
Concurrent use of herbal and prescribed medicine by patients in primary health care clinics, South Africa.南非初级卫生保健诊所患者中草药与处方药的同时使用情况。
Afr J Prim Health Care Fam Med. 2023 Jun 29;15(1):e1-e7. doi: 10.4102/phcfm.v15i1.3829.
3
Shikonin Reduces Growth of Docetaxel-Resistant Prostate Cancer Cells Mainly through Necroptosis.紫草素主要通过坏死性凋亡降低多西他赛耐药前列腺癌细胞的生长。
Cancers (Basel). 2021 Feb 20;13(4):882. doi: 10.3390/cancers13040882.
4
Artesunate Inhibits Growth of Sunitinib-Resistant Renal Cell Carcinoma Cells through Cell Cycle Arrest and Induction of Ferroptosis.青蒿琥酯通过细胞周期阻滞和诱导铁死亡抑制舒尼替尼耐药肾癌细胞的生长。
Cancers (Basel). 2020 Oct 27;12(11):3150. doi: 10.3390/cancers12113150.

本文引用的文献

1
Automated alerts and reminders targeting patients: A review of the literature.针对患者的自动警报和提醒:文献综述
Patient Educ Couns. 2016 Jun;99(6):953-9. doi: 10.1016/j.pec.2015.12.010. Epub 2015 Dec 21.
2
Disease severity is associated with the use of complementary medicine to treat or manage type-2 diabetes: data from the 2002 and 2007 National Health Interview Survey.疾病严重程度与使用补充医学来治疗或控制 2 型糖尿病有关:来自 2002 年和 2007 年全国健康访谈调查的数据。
BMC Complement Altern Med. 2012 Oct 22;12:193. doi: 10.1186/1472-6882-12-193.
3
High-priority drug-drug interactions for use in electronic health records.高优先级药物相互作用,用于电子健康记录。
J Am Med Inform Assoc. 2012 Sep-Oct;19(5):735-43. doi: 10.1136/amiajnl-2011-000612. Epub 2012 Apr 26.
4
Feasibility and potential benefit of collecting Complementary and Alternative Medicine data through a computerized patient interview.通过计算机化患者访谈收集补充与替代医学数据的可行性及潜在益处。
AMIA Annu Symp Proc. 2011;2011:1217-23. Epub 2011 Oct 22.
5
A successful model and visual design for creating context-aware drug-drug interaction alerts.一种用于创建情境感知药物相互作用警报的成功模型和可视化设计。
AMIA Annu Symp Proc. 2011;2011:339-48. Epub 2011 Oct 22.
6
Dietary supplement use in the United States, 2003-2006.美国人膳食补充剂使用情况,2003-2006 年。
J Nutr. 2011 Feb;141(2):261-6. doi: 10.3945/jn.110.133025. Epub 2010 Dec 22.
7
Use of herbal products and potential interactions in patients with cardiovascular diseases.中草药产品的使用与心血管疾病患者的潜在相互作用。
J Am Coll Cardiol. 2010 Feb 9;55(6):515-25. doi: 10.1016/j.jacc.2009.07.074.
8
Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007.补充和替代医学(CAM)的费用及看CAM从业者的频率:美国,2007年
Natl Health Stat Report. 2009 Jul 30(18):1-14.
9
Interactions between herbal medicines and prescribed drugs: an updated systematic review.中草药与处方药的相互作用:最新系统评价。
Drugs. 2009;69(13):1777-98. doi: 10.2165/11317010-000000000-00000.
10
Complementary and alternative medicine use among adults and children: United States, 2007.2007年美国成人和儿童使用补充与替代医学的情况
Natl Health Stat Report. 2008 Dec 10(12):1-23.

患者对草药-药物-疾病相互作用警报的需求和偏好:一项结构化访谈研究。

Patient needs and preferences for herb-drug-disease interaction alerts: a structured interview study.

作者信息

Christensen Carrie M, Morris Rebecca S, Kapsandoy Seraphine Chepkemoi, Archer Melissa, Kuang Jinqiu, Shane-McWhorter Laura, Bray Bruce E, Zeng-Treitler Qing

机构信息

Department of Biomedical Informatics, University of Utah School of Medicine, 421 Wakara Way, Suite 140, Salt Lake City, UT, 84108, USA.

Drug Regimen and Review Center, University of Utah College of Pharmacy, Salt Lake City, UT, USA.

出版信息

BMC Complement Altern Med. 2017 May 19;17(1):272. doi: 10.1186/s12906-017-1630-6.

DOI:10.1186/s12906-017-1630-6
PMID:28526079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5438528/
Abstract

BACKGROUND

While complementary and alternative medicine (CAM) is commonly used in the United States and elsewhere, and hazardous interactions with prescription drugs can occur, patients do not regularly communicate with physicians about their CAM use. The objective of this study was to discover patient information needs and preferences for herb-drug-disease interaction alerts.

METHODS

We recruited 50 people from several locations within the University of Utah Hospital to participate in this structured interview study. They were asked to provide their preferences for the herb-drug-disease interaction alerts. Qualitative methods were used to reveal the themes that emerged from the interviews.

RESULTS

Most participants reported they had previously used, or they were currently using, CAM therapies. The majority had made the effort to inform their healthcare provider(s) about their CAM usage, although some had not. We found that most respondents were interested in receiving alerts and information about potential interactions. Many preferred to receive the alerts in a variety of ways, both in person and electronically.

CONCLUSIONS

In addition to conventional medicine, many patients regularly use complementary and alternative therapies. And yet, communication between patients and providers about CAM use is not consistent. There is a demand for interventions in health care that provide timely, integrative communication support. Delivering the herb-drug-disease alerts through multiple channels could help meet critical patient information needs.

摘要

背景

虽然补充和替代医学(CAM)在美国及其他地区被广泛使用,且可能与处方药发生有害相互作用,但患者通常不会定期与医生交流他们使用补充和替代医学的情况。本研究的目的是发现患者对草药-药物-疾病相互作用警报的信息需求和偏好。

方法

我们从犹他大学医院的多个地点招募了50人参与这项结构化访谈研究。我们询问他们对草药-药物-疾病相互作用警报的偏好。采用定性方法揭示访谈中出现的主题。

结果

大多数参与者报告他们之前使用过或目前正在使用补充和替代医学疗法。大多数人努力告知他们的医疗服务提供者其补充和替代医学的使用情况,尽管有些人没有。我们发现大多数受访者有兴趣接收关于潜在相互作用的警报和信息。许多人更喜欢通过多种方式接收警报,包括面对面和电子方式。

结论

除了传统医学外,许多患者经常使用补充和替代疗法。然而,患者与医疗服务提供者之间关于补充和替代医学使用的沟通并不一致。医疗保健领域需要提供及时、综合沟通支持的干预措施。通过多种渠道提供草药-药物-疾病警报有助于满足患者关键的信息需求。